{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T07:41:35Z","timestamp":1774597295084,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jtct.2023.07.007","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T21:23:01Z","timestamp":1689024181000},"page":"581.e1-581.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation"],"prefix":"10.1016","volume":"29","author":[{"given":"Abel","family":"Santos Carreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4567-3682","authenticated-orcid":false,"given":"Maria Queralt","family":"Salas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0520-4312","authenticated-orcid":false,"given":"Mats","family":"Remberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3748-3117","authenticated-orcid":false,"given":"Igor","family":"Novitzky-Basso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9251-3609","authenticated-orcid":false,"given":"Arjun Datt","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilson","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Pasic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Mazzulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5297-6406","authenticated-orcid":false,"given":"Christine","family":"Cserti-Gazdewich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis (Dong Hwan)","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fotios V.","family":"Michelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auro","family":"Viswabandya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Gerbitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey Howard","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajat","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moustapha","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.07.007_bib0001","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/bmt.2015.162","article-title":"Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival","volume":"50","author":"Lunde","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.07.007_bib0002","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3324\/haematol.2009.016758","article-title":"Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type","volume":"95","author":"Silva Lde","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.07.007_bib0003","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/tid.12233","article-title":"The polyomavirus puzzle: is host immune response beneficial in controlling BK virus after adult hematopoietic cell transplantation?","volume":"16","author":"Satyanarayana","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1016\/j.jtct.2023.07.007_bib0004","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1182\/bloodadvances.2019000802","article-title":"Presentation of BK polyomavirus-associated hemorrhagic cystitis after allogeneic hematopoietic cell transplantation","volume":"4","author":"Imlay","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.07.007_bib0005","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/s41409-022-01665-y","article-title":"Incidence, risk factors and outcome of BK virus hemorrhagic cystitis following allogenic hematopoietic cell transplantation: a retrospective cohort study","volume":"57","author":"Saade","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.07.007_bib0006","doi-asserted-by":"crossref","unstructured":"Karagun BS, Aygunes U, Eken A, Akbas T, Melek E, Antmen B. Risk assessment for BK virus-associated hemorrhagic cystitis after pediatric hematopoietic stem cell transplant: a single-center retrospective cross-sectional study [e-pub ahead of print June 17, 2021]. Exp Clin Transplant. doi: 10.6002\/ect.2021.0104.","DOI":"10.6002\/ect.2021.0104"},{"key":"10.1016\/j.jtct.2023.07.007_bib0007","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.07.007_bib0008","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3389\/fimmu.2019.02668","article-title":"Mechanisms of graft-versus-host disease prevention by post-transplantation cyclophosphamide: an evolving understanding","volume":"10","author":"Nunes","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2023.07.007_bib0009","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood.2021011281","article-title":"HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis","volume":"138","author":"Gooptu","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.07.007_bib0010","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41409-019-0771-2","article-title":"Incorporating posttransplant cyclophosphamide-based prophylaxis as standard-of-care outside the haploidentical setting: challenges and review of the literature","volume":"55","author":"Garcia-Cadenas","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.07.007_bib0011","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1038\/s41409-021-01328-4","article-title":"Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide","volume":"56","author":"Esquirol","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.07.007_bib0012","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41419-021-03740-6","article-title":"Single-cell analysis reveals urothelial cell heterogeneity and regenerative cues following cyclophosphamide-induced bladder injury","volume":"12","author":"Cheng","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jtct.2023.07.007_bib0013","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/ejh.13321","article-title":"Reduced intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemia","volume":"103","author":"Salas","year":"2019","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2023.07.007_bib0014","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s41409-020-0813-9","article-title":"Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHD","volume":"55","author":"Salas","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.07.007_bib0015","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.bbmt.2018.07.008","article-title":"Reduced-intensity conditioning and dual T lymphocyte suppression with antithymocyte globulin and post-transplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical hematopoietic stem cell transplants for hematological malignancies","volume":"24","author":"Law","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.07.007_bib0016","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41409-017-0053-9","article-title":"Reduction of severe acute graft-versus-host disease using a combination of pre transplant anti-thymocyte globulin and post-transplant cyclophosphamide in matched unrelated donor transplantation","volume":"53","author":"Deotare","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.07.007_bib0017","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1200\/JCO.1995.13.5.1103","article-title":"Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation","volume":"13","author":"Bedi","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.07.007_bib0018","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.bbmt.2018.04.009","article-title":"Efficacy of cidofovir in treatment of BK virus-induced hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients","volume":"24","author":"Coomes","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.07.007_bib0019","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.07.007_bib0020","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1399-0012.2007.00705.x","article-title":"Hemorrhagic cystitis: a retrospective single-center survey","volume":"21","author":"Hassan","year":"2007","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2023.07.007_bib0021","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12677","article-title":"Incidence and risk factor of hemorrhagic cystitis after allogeneic transplantation with fludarabine, busulfan, and anti-thymocyte globulin myeloablative conditioning","volume":"19","author":"Lam","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jtct.2023.07.007_bib0022","first-page":"225","article-title":"Association of busulfan area under the curve with veno-occlusive disease following BMT","volume":"17","author":"Dix","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.07.007_bib0023","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.bmt.1702377","article-title":"The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity","volume":"25","author":"Hassan","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.07.007_bib0024","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/BF00558081","article-title":"Pharmacokinetic and metabolic studies of high-dose busulphan in adults","volume":"36","author":"Hassan","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jtct.2023.07.007_bib0025","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0006-2952(94)90049-3","article-title":"Microsomal metabolism of N,N-diethylacetamide and N,N-dimethylacetamide and their effects on drug-metabolizing enzymes of rat liver","volume":"48","author":"Silvia","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jtct.2023.07.007_bib0026","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00280-013-2284-9","article-title":"Population pharmacokinetics of dimethylacetamide in children during standard and once-daily IV busulfan administration","volume":"72","author":"Trame","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jtct.2023.07.007_bib0027","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.3389\/fonc.2019.01217","article-title":"The graft-versus-leukemia effect in AML","volume":"9","author":"Sweeney","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtct.2023.07.007_bib0028","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.lfs.2018.12.018","article-title":"Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: old drug with a new vision","volume":"218","author":"Iqubal","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.jtct.2023.07.007_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/341787","article-title":"Recent advances in the biology of the urothelium and applications for urinary bladder dysfunction","volume":"2014","author":"Romih","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jtct.2023.07.007_bib0030","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/tid.12455","article-title":"Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients","volume":"17","author":"Ruggeri","year":"2015","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"10.1016\/j.jtct.2023.07.007_bib0031","doi-asserted-by":"crossref","first-page":"e13601","DOI":"10.1111\/tid.13601","article-title":"Risk factors of BK viral hemorrhagic cystitis in allogenic hematopoietic stem cell transplantation","volume":"23","author":"Kaphan","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jtct.2023.07.007_bib0032","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.bbmt.2020.01.013","article-title":"Infections after allogenic transplant with post-transplant cyclophosphamide: impact of donor HLA matching","volume":"26","author":"Oltolini","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.07.007_bib0033","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/BS9.0000000000000110","article-title":"Risk factors associated with hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation","volume":"4","author":"Shen","year":"2022","journal-title":"Blood Sci"},{"key":"10.1016\/j.jtct.2023.07.007_bib0034","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1080\/10428194.2021.1966781","article-title":"Lower dose of ATG combined with post-transplant cyclophosphamide for HLA matched RIC alloHCT is associated with effective control of GVHD and less viral infections","volume":"62","author":"Salas","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2023.07.007_bib0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/jgid.jgid_139_21","article-title":"BK polyomavirus hemorrhagic cystitis in hematopoietic cell transplant recipients","volume":"14","author":"Lionel","year":"2022","journal-title":"J Glob Infect Dis"},{"key":"10.1016\/j.jtct.2023.07.007_bib0036","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s15010-016-0872-4","article-title":"Reactivation of polyomavirus in the genitourinary tract is significantly associated with severe GvHD and oral mucositis following allogeneic stem cell transplantation","volume":"44","author":"Peterson","year":"2016","journal-title":"Infection"},{"key":"10.1016\/j.jtct.2023.07.007_bib0037","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/blood-2007-11-122945","article-title":"A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor","volume":"111","author":"Gallinaro","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.07.007_bib0038","first-page":"491","article-title":"Beyond immunohaematology: the role of the ABO blood group in human diseases","volume":"11","author":"Liumbruno","year":"2013","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jtct.2023.07.007_bib0039","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/vox.12786","article-title":"Biologic roles of the ABH and Lewis histo-blood group antigens part II: thrombosis, cardiovascular disease and metabolism","volume":"114","author":"Stowell","year":"2019","journal-title":"Vox Sang"},{"key":"10.1016\/j.jtct.2023.07.007_bib0040","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1182\/blood-2018-06-855528","article-title":"Blood group alters platelet binding kinetics to von Willebrand factor and consequently platelet function","volume":"133","author":"Dunne","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.07.007_bib0041","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood.2020005843","article-title":"The relationship between ABO blood group, von Willebrand factor, and primary hemostasis","volume":"136","author":"Ward","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.07.007_bib0042","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jtct.2022.05.012","article-title":"A clinical review of the different strategies to minimize hemorrhagic cystitis associated with the use of post-transplantation cyclophosphamide in an allogeneic transplant","volume":"28","author":"Ngo","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.07.007_bib0043","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1038\/s41409-021-01364-0","article-title":"Use of high-dose mesna and hyperhydration leads to lower incidence of hemorrhagic cystitis after posttransplant cyclophosphamide-based allogeneic transplantation","volume":"56","author":"Mac","year":"2021","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723013908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723013908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:10:43Z","timestamp":1763003443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723013908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2666636723013908"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.07.007","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}